TherapeuticsMD Inc (AMEX:TXMD) - Share price - Overview

Stock Report

TherapeuticsMD Inc TXMD

Last Price
$3.98

Day Change
-0.29|-6.79%

As of 26/05/2017
17:56:46 EDT | USD
Minimum 15 Minutes Delay.

Last Close4.27
Day Range3.96 - 4.35
Mkt Cap811.60Mil
52-Wk Range3.50 - 9.29
Yield %-
ISINUS88338N1072
Volume1,751,219
P/E-8.65
P/S42.55
P/CF-11.15

Share Price

Financials
201420152016
More ...
Income Statement
Revenue15.0320.1419.36
Operating Income-54.04-85.19-90.25
Net Income-54.22-85.08-89.88
Basic EPS-0.36-0.49-0.46
Avg. Diluted Shares Outstanding150173196
Balance Sheet
Current Assets56.2470.68139.41
Non Current Assets2.843.053.06
Total Assets59.0873.73142.47
Current Liabilities10.6910.6714.98
Total Liabilities10.6910.6714.98
Total Equity48.3963.06127.49
Cash Flow
Operating Cash Flow-45.52-79.04-69.14
Capital Expenditure-0.62-0.58-1.24
Free Cash Flow-46.14-79.63-70.38

In millions, except "Basic EPS". Currency is USD.

Company Profile

TherapeuticsMD Inc is a women's health care company focused on creating & commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for commercialization of advanced hormone therapy pharmaceutical product.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

159
Key Stats
More ...
Price/Earning TTM-9.28
Price/Book7.89
Price/Sales TTM43.26
Rev Growth (3 year avg)30.17
EPS Growth (3 year avg)-
Operating Margin % TTM-466.27
Net Margin % TTM-464.32
ROE TTM-94.33
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.